Post-PCV13 Drop in Streptococcus pneumoniae Bacteremia

Share this content:
Post-PCV13 Drop in <i>Streptococcus pneumoniae</i> Bacteremia
Post-PCV13 Drop in Streptococcus pneumoniae Bacteremia

MONDAY, March 13, 2017 (HealthDay News) -- Introduction of seven-valent and 13-valent pneumococcal conjugate vaccine (PCV13) correlated with a reduction in Streptococcus pneumoniae bacteremia, according to a review published online March 10 in Pediatrics.

Tara L. Greenhow, M.D., from Kaiser Permanente Northern California in San Francisco, and colleagues conducted a retrospective review of the electronic medical records of all blood cultures collected for children aged 3 to 36 months at Kaiser Permanente Northern California. A total of 57,733 blood cultures were collected from Sept. 1, 1998, to Aug. 31, 2014, in outpatient clinics, emergency departments, and in the first 24 hours of hospitalization.

The researchers observed a 95.3 percent reduction of Streptococcus pneumoniae bacteremia after implementation of routine immunization with the pneumococcal conjugate vaccine, from 74.5 to 10 to 3.5 per 100,000 children per year by the post-PCV13 period. Escherichia coli, Salmonella spp, and Staphylococcus aureus caused 77 percent of bacteremia as pneumococcal rates decreased. In the post-PCV13 period, 76 percent of all bacteremia occurred with a source.

"In the United States, routine immunizations have made bacteremia in the previously healthy toddler a rare event," the authors write. "New guidelines are needed to approach the previously healthy febrile toddler in the outpatient setting."

The research was supported by a grant from the Kaiser Permanente Northern California Community Benefit Program.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »